Advertisement
Screener

GeneDx Holdings Corp. (WGS) Payments of Merger Related Costs, Financing Activities

GeneDx Holdings Corp. Payments of Merger Related Costs, Financing Activities

GeneDx Holdings Corp. (WGS) reported Payments of Merger Related Costs, Financing Activities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2023-03-16

  • GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-12-31 was $0.00.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2021 was $51.76M.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2020 was $0.00.
  • GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2019 was $0.00.
Period endPayments of Merger Related Costs, Financing Activities 3 monthPayments of Merger Related Costs, Financing Activities 6 monthPayments of Merger Related Costs, Financing Activities 9 monthPayments of Merger Related Costs, Financing Activities 12 month
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$0.00
derived: sum of 2 quarters · filed 2023-03-16
$0.00
derived: sum of 3 quarters · filed 2023-03-16
$0.00
10-K · filed 2023-03-16
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$0.00
derived: sum of 2 quarters · filed 2022-11-14
$0.00
10-Q · filed 2022-11-14
$0.00
derived: sum of 4 quarters · filed 2023-03-16
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$0.00
10-Q · filed 2022-08-15
$0.00
derived: sum of 3 quarters · filed 2023-03-16
$48.98M
derived: sum of 4 quarters · filed 2023-03-16
2022-03-31$0.00
10-Q · filed 2022-05-12
$0.00
derived: sum of 2 quarters · filed 2023-03-16
$48.98M
derived: sum of 3 quarters · filed 2023-03-16
$50.51M
derived: sum of 4 quarters · filed 2023-03-16
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$48.98M
derived: sum of 2 quarters · filed 2023-03-16
$50.51M
derived: sum of 3 quarters · filed 2023-03-16
$51.76M
10-K · filed 2023-03-16
2021-09-30$48.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$50.51M
derived: sum of 2 quarters · filed 2022-11-14
$51.76M
10-Q · filed 2022-11-14
$51.76M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$1.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$2.78M
10-Q · filed 2022-08-15
$2.78M
derived: sum of 3 quarters · filed 2023-03-16
2021-03-31$1.25M
10-Q · filed 2022-05-12
$1.25M
derived: sum of 2 quarters · filed 2023-03-16
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$0.00
10-K · filed 2023-03-16
2020-09-30$0.00
10-Q · filed 2021-11-15
2019-12-31$0.00
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B